Literature DB >> 30703253

Decreased glucocorticoid receptor expression during critical illness.

Alice G Vassiliou1, Georgios Floros2, Edison Jahaj2, Georgios Stamogiannos2, Sofianna Gennimata2, Dimitra A Vassiliadi3, Stylianos Tsagarakis3, Marinella Tzanela3, Ioannis Ilias4, Stylianos E Orfanos1,2, Anastasia Kotanidou1,2, Ioanna Dimopoulou2.   

Abstract

INTRODUCTION: In critically ill patients, the hypothalamic-pituitary-adrenal axis is activated, resulting in increased serum cortisol concentrations. However, in some patients, especially those with sepsis, cortisol levels are relatively low for the degree of illness severity. Therefore, in the present project, we aim to characterize the time course of glucocorticoid receptor (GCR) alpha and beta expression in peripheral polymorphonuclear cells of critically ill septic or nonseptic patients using real-time PCR.
DESIGN: A prospective observational study conducted on 32 critically ill adults not receiving steroids, in a university-affiliated, multidisciplinary intensive care unit (ICU). Blood samples were collected for measurement of glucocorticoid receptor expression within 24-48 hours of admission to the ICU and at days 4, 8 and 13 after admission, reflecting the acute and chronic phase of the illness.
RESULTS: During ICU stay, patients expressed over time reduced levels of both GCR-α and GCR-β mRNA. More specifically, GCR-α mRNA expression was decreased fourfold 4 days after admission (P < 0.0001) and remained low up to 2 weeks after admission (P < 0.001). On the other hand, GCR-β mRNA levels remained stable shortly after admission, but approx. one week after admission, its levels decreased threefold (P < 0.01) and remained reduced up to 2 weeks after admission (P < 0.001). DISCUSSION: Our results suggest that critically ill patients have highly variable expression of alpha and beta GCR, and moreover, the levels of both receptors decrease during ICU stay. Taken together, these might explain the differential responsiveness of patients to exogenous steroid administration or to endogenous cortisol secretion.
© 2019 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  cortisol; critical illness; glucocorticoid receptors; mRNA expression; real-time PCR; sepsis

Mesh:

Substances:

Year:  2019        PMID: 30703253     DOI: 10.1111/eci.13073

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Physiologic effects of stress dose corticosteroids in in-hospital cardiac arrest (CORTICA): A randomized clinical trial.

Authors:  Spyros D Mentzelopoulos; Evanthia Pappa; Sotirios Malachias; Charikleia S Vrettou; Achilleas Giannopoulos; George Karlis; George Adamos; Ioannis Pantazopoulos; Aikaterini Megalou; Zafeiris Louvaris; Vassiliki Karavana; Epameinondas Aggelopoulos; Gerasimos Agaliotis; Marielen Papadaki; Aggeliki Baladima; Ismini Lasithiotaki; Fotini Lagiou; Prodromos Temperikidis; Aggeliki Louka; Andreas Asimakos; Marios Kougias; Demosthenes Makris; Epameinondas Zakynthinos; Maria Xintara; Maria-Eirini Papadonta; Aikaterini Koutsothymiou; Spyros G Zakynthinos; Eleni Ischaki
Journal:  Resusc Plus       Date:  2022-05-26

Review 2.  Glucocorticoids and the Brain after Critical Illness.

Authors:  Alice R Hill; Joanna L Spencer-Segal
Journal:  Endocrinology       Date:  2021-03-01       Impact factor: 4.736

3.  Restrained expression of canine glucocorticoid receptor splice variants α and P prognosticates fatal disease outcome in SIRS.

Authors:  Brigitta Margit Kállai; Judit Csöndes; Gergely Kiss; Lilla Bodrogi; Zsolt Rónai; Tamás Mészáros
Journal:  Sci Rep       Date:  2021-12-30       Impact factor: 4.379

Review 4.  General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.

Authors:  Gianfranco Umberto Meduri; George P Chrousos
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-22       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.